RLYB
Rallybio Corp
NASDAQ: RLYB · HEALTHCARE · BIOTECHNOLOGY
$8.98
+1.13% today
Updated 2026-04-30
Market cap
$46.55M
P/E ratio
—
P/S ratio
54.25x
EPS (TTM)
$-1.59
Dividend yield
—
52W range
$2 – $11
Volume
0.2M
Rallybio Corp (RLYB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-14.2%
Last 4 quarters
Revenue YoY growth
+484.2%
Most recent quarter
EPS YoY growth
-708.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-0.5%
2026-03-17
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-1.52 | -891.5% | $9.41 | $9.36 | -0.5% |
| 2025-11-06 | $0.36 | +280.0% | $0.63 | $0.63 | +0.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.15 | $-1.52 | -891.5% | $222000.00 | +484.2% |
| 2025-09-30 | $-0.20 | $0.36 | +280.0% | $212000.00 | -29.1% |
| 2025-06-30 | $-0.24 | $-0.43 | -81.7% | $212000.00 | -29.1% |
| 2025-03-31 | $-0.28 | $-0.21 | +25.0% | $212000.00 | — |
| 2024-12-31 | $-0.30 | $0.25 | +183.3% | $38000.00 | -83.3% |
| 2024-09-30 | $-0.35 | $-0.26 | +25.7% | $299000.00 | — |
| 2024-06-30 | $-0.37 | $-0.67 | -81.1% | $299000.00 | — |
| 2024-03-31 | $-0.47 | $-0.47 | +0.0% | — | — |
| 2023-12-31 | $-0.45 | $-0.50 | -11.1% | $228000.00 | — |
| 2023-09-30 | $-0.51 | $-0.45 | +11.8% | — | — |
| 2023-06-30 | $-0.48 | $-0.46 | +4.2% | — | — |
| 2023-03-31 | $-0.49 | $-0.43 | +12.2% | — | — |
Frequently asked questions
Has Rallybio Corp beaten earnings estimates?
Rallybio Corp has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -14.2% over the last 4 quarters.
How does RLYB stock react to earnings?
RLYB stock has moved an average of -0.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Rallybio Corp's revenue growth rate?
Rallybio Corp reported year-over-year revenue growth of +484.2% in its most recent quarter, with EPS growing -708.0% year-over-year.